VRTX | Vertex Pharmaceuticals Inc | $134.5b | $535.84 | -0.8% | 487.1K |
REGN | Regeneron Pharmaceuticals Inc | $100.7b | $957.03 | +0.5% | 476.6K |
INSM | Insmed, Inc. | $22.9b | $120.39 | +2.6% | 1.1M |
BMRN | BioMarin Pharmaceuticals Inc | $10.8b | $57.24 | +0.9% | 875.0K |
KRYS | Krystal Biotech, Inc. Common Stock | $9.0b | $307.50 | -0.2% | 79.1K |
CRSP | CRISPR Therapeutics AG | $4.8b | $42.33 | -0.9% | 1.6M |
FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
BEAM | Beam Therapeutics Inc. Common Stock | $2.7b | $23.05 | -5.0% | 1.8M |
VCEL | Vericel Corporation | $2.1b | $56.95 | -0.9% | 490.4K |
SRPT | Sarepta Therapeutics,, Inc. Common Stock | $2.0b | $15.85 | +0.4% | 1.1M |
PGEN | Precigen, Inc. Common Stock | $1.9b | $4.51 | -3.0% | 3.1M |
BLFS | BioLife Solutions Inc. | $1.8b | $38.60 | 0.0% | N/A |
NTLA | Intellia Therapeutics, Inc | $1.7b | $9.81 | -8.0% | 8.8M |
QURE | uniQure N.V. | $1.7b | $24.05 | -3.2% | 1.3M |
PCRX | Pacira BioSciences, Inc. Common Stock | $1.5b | $36.45 | +0.0% | 1.8M |
TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.3b | $4.22 | -2.9% | 2.1M |
MGTX | MeiraGTx Holdings plc Ordinary Shares | $0.9b | $9.19 | +4.6% | 597.5K |
CYRX | CryoPort, Inc. Common Stock | $0.8b | $19.89 | -1.0% | 304.7K |
PRME | Prime Medicine, Inc. Common Stock | $0.8b | $4.32 | +9.4% | 5.5M |
SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $2.02 | +0.2% | 3.0M |
SLDB | Solid Biosciences Inc. Common Stock | $0.7b | $6.84 | -2.3% | 857.0K |
FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.7b | $12.25 | +0.9% | 731.4K |
DSGN | Design Therapeutics, Inc. Common Stock | $0.6b | $10.47 | -1.0% | 132.2K |
NGNE | Neurogene, Inc. Common Stock | $0.5b | $23.95 | +0.3% | 168.4K |
RGNX | REGENXBIO Inc. | $0.5b | $7.64 | -4.9% | 596.7K |
EDIT | Editas Medicine, Inc. Common Stock | $399.3m | $2.12 | +1.2% | 2.6M |
ALLO | Allogene Therapeutics, Inc. Common Stock | $386.9m | $0.83 | +1.4% | 11.2M |
IRD | Opus Genetics, Inc. Common Stock | $327.0m | $4.03 | -1.7% | 631.5K |
KYTX | Kyverna Therapeutics, Inc. Common Stock | $319.1m | $5.26 | +0.3% | 673.4K |
BNTC | Benitec Biopharma Inc. Common Stock | $293.1m | $9.03 | -0.9% | 90.3K |
RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $275.5m | $2.28 | -4.4% | 1.4M |
LXEO | Lexeo Therapeutics, Inc. Common Stock | $255.3m | $2.90 | -1.4% | 357.1K |
OCGN | Ocugen, Inc. Common Stock | $252.7m | $0.83 | -5.2% | 16.4M |
ABEO | Abeona Therapeutics Inc. Common Stock | $243.0m | $2.38 | +5.5% | 3.1M |
CABA | Cabaletta Bio, Inc. Common Stock | $240.8m | $1.29 | -3.8% | 2.9M |
KRRO | Korro Bio, Inc. Common Stock | $233.5m | $13.64 | -4.8% | 67.0K |
DTIL | Precision BioSciences, Inc. Common Stock | $192.4m | $7.58 | -6.0% | 374.8K |
TRDA | Entrada Therapeutics, Inc. Common Stock | $183.8m | $5.08 | -1.5% | 627.6K |
INO | Inovio Pharmaceuticals, Inc. | $171.6m | $1.42 | -1.7% | 5.0M |
MXCT | MaxCyte, Inc. Common Stock | $150.7m | $1.18 | +0.8% | 1.2M |
VYGR | Voyager Therapeutics, Inc. Common Stock | $112.8m | $1.72 | +1.5% | 667.5K |
ENGN | enGene Therapeutics Inc. Common Stock | $108.6m | $2.31 | +5.7% | 3.6M |
CBUS | Cibus, Inc. Class A Common Stock | $87.1m | $1.13 | +3.2% | 141.4K |
GNLX | Genelux Corporation Common Stock | $86.9m | $1.86 | -1.3% | 175.7K |
SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -17.5% | 6.9M |
TNYA | Tenaya Therapeutics, Inc. Common Stock | $82.1m | $0.36 | -0.1% | 1.3M |
GRML | Greenland Mines Ltd. Common Stock | $57.2m | $3.70 | -6.1% | 414.8K |
CRBU | Caribou Biosciences, Inc. Common Stock | $49.3m | $0.36 | -4.6% | 1.5M |
TIL | Instil Bio, Inc. Common Stock | $45.2m | $6.11 | -3.0% | 49.1K |
MGX | Metagenomi Therapeutics, Inc. Common Stock | $28.7m | $0.69 | -3.3% | 117.8K |